Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 17, 2021 - Issue 7
Submit an article Journal homepage
2,729
Views
7
CrossRef citations to date
0
Altmetric
Research Paper

B16 melanoma control by anti-PD-L1 requires CD8+ T cells and NK cells: application of anti-PD-L1 Abs and Trp2 peptide vaccines

Sunhee Jia Department of Microbiology, School of Medicine, Kangwon National University, Chuncheon, KoreaORCID Iconhttps://orcid.org/0000-0002-4411-2181View further author information
ORCID Icon,
Jaeyeon Leea Department of Microbiology, School of Medicine, Kangwon National University, Chuncheon, Korea;b Interdisciplinary Graduate Program in BIT Medical Convergence, Kangwon National University, Chuncheon, KoreaORCID Iconhttps://orcid.org/0000-0001-6754-0165View further author information
ORCID Icon,
Eung Suk Leec Scripps Korea Antibody Institute, Chuncheon, KoreaView further author information
,
Dae Hee Kimc Scripps Korea Antibody Institute, Chuncheon, KoreaORCID Iconhttps://orcid.org/0000-0002-3845-0870View further author information
ORCID Icon &
Jeong-Im Sina Department of Microbiology, School of Medicine, Kangwon National University, Chuncheon, Korea;b Interdisciplinary Graduate Program in BIT Medical Convergence, Kangwon National University, Chuncheon, KoreaCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0003-4700-7704View further author information
ORCID Icon
Pages 1910-1922 | Received 07 Oct 2020, Accepted 16 Dec 2020, Published online: 31 Jan 2021

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ryan M Reyes, Chenghao Zhang, Yilun Deng, Niannian Ji, Neelam Mukherjee, Alvaro S Padron, Curtis A Clark, Robert S Svatek & Tyler J Curiel. (2021) CD122-targeted interleukin-2 and αPD-L1 treat bladder cancer and melanoma via distinct mechanisms, including CD122-driven natural killer cell maturation. OncoImmunology 10:1.
Read now

Articles from other publishers (6)

Davis Y. Torrejon, Mildred Galvez, Gabriel Abril-Rodriguez, Katie M. Campbell, Egmidio Medina, Agustin Vega-Crespo, Anusha Kalbasi, Begoña Comin-Anduix & Antoni Ribas. (2023) Antitumor Immune Responses in B2M -Deficient Cancers . Cancer Immunology Research 11:12, pages 1642-1655.
Crossref
Jiaying Zheng, Lingxiao Wang, Shunyi Zhao, Wenjing Zhang, Yuzhou Chang, Dale B Bosco, Tao Huang, Aastha Dheer, Shan Gao, Shengze Xu, Katayoun Ayasoufi, Rawan Al-Kharboosh, Fangfang Qi, Manling Xie, Aaron J Johnson, Haidong Dong, Alfredo Quiñones-Hinojosa & Long-Jun Wu. (2023) TREM2 mediates MHCII-associated CD4+ T-cell response against gliomas. Neuro-Oncology.
Crossref
Si-Wei Zhang, Han Wang, Xiao-Hong Ding, Yu-Ling Xiao, Zhi-Ming Shao, Chao You, Ya-Jia Gu & Yi-Zhou Jiang. (2023) Bidirectional crosstalk between therapeutic cancer vaccines and the tumor microenvironment: Beyond tumor antigens. Fundamental Research 3:6, pages 1005-1024.
Crossref
Yunchao Zhang, Chenxin Liu, Chunjie Wu & Linjiang Song. (2023) Natural peptides for immunological regulation in cancer therapy: Mechanism, facts and perspectives. Biomedicine & Pharmacotherapy 159, pages 114257.
Crossref
Inken Salewski, Steffen Kuntoff, Andreas Kuemmel, Rico Feldtmann, Stephan B. Felix, Larissa Henze, Christian Junghanss & Claudia Maletzki. (2021) Combined vaccine-immune-checkpoint inhibition constitutes a promising strategy for treatment of dMMR tumors. Cancer Immunology, Immunotherapy 70:12, pages 3405-3419.
Crossref
Jaeyeon Lee, Jiyoon Kim & Jeong-Im Sin. (2021) B16 melanomas evade antitumor immunity by the loss of epitope presentation and the acquisition of tumor resistance to granzyme B. Cellular Immunology 367, pages 104394.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.